Email Updates

Search form

You are here

AIDS Vaccines

There is momentum and promise in the search for an AIDS vaccine.

An effective preventive AIDS vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available—and an AIDS vaccine would play a powerful role in ensuring the end to the AIDS epidemic. 

While effective vaccines remain years away, there are more reasons for hope than ever before. Researchers are expanding on the result of a 2009 trial that showed, for the first time, that a vaccine can reduce the risk of HIV infection. They’re also pursuing groundbreaking research with other novel vaccine strategies, including broadly neutralizing antibodies that target a wide range of HIV strains. At the same time, there is also exciting work in efforts to understand if and how to cure HIV in people who are already infected. The timeline for this work is long and uncertain. Here, too, advocacy is needed to sustain momentum.

Today’s momentum depends on sustained funding. Policy makers and funders around the world must have the courage to sustain vital AIDS vaccine research for years to come, and advocates must keep the pressure on them to maintain their commitments.

What We're Reading

An accessible article on the state of the HIV vaccine field that notes reasons for optimism, despite the complexity of the virus that has made the search so difficult.

December 4, 2014

A report from the Science Speaks blog (a project of the Center for Global Health Policy) on the results of HVTN 097. This small trial is part of the suite of studies that aim to build on the positive results of the Thai prime-boost trial, RV144. HVTN 097 had good news—this piece explains the implications in plain language.

October 29, 2014
Science Speaks
Subscribe to RSS - AIDS Vaccines